StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > There is more than meets the eyes.

<< Previous

Bullboard Posts

Next >>

Comment by StockscoutXon Apr 05, 2021 9:49pm

150 Views

Post# 32939565

RE:RE:There is more than meets the eyes.

Northerencents. Looks like the jabroni is the one that you look in the mirror every day. The one that lost money. I lost none. Still have interest in this stock long term.

<< Previous

Bullboard Posts

Next >>

Three micro-cap value stocks trading at peak pessimism